 |
|
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Tommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Clin Mol Hepatol. 2019;25(4):360-365. Published online 2019 May 2 DOI: https://doi.org/10.3350/cmh.2019.0022
|
|
Citations to this article as recorded by
 Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
Olga Tronina, Michał Brzdęk, Dorota Zarębska-Michaluk, Dorota Dybowska, Beata Lorenc, Ewa Janczewska, Włodzimierz Mazur, Anna Parfieniuk-Kowerda, Anna Piekarska, Rafał Krygier, Jakub Klapaczyński, Hanna Berak, Jerzy Jaroszewicz, Aleksander Garlicki, Krzys
Viruses.2023; 15(3): 677. CrossRef ASPARTATE PLATELET RATIO INDEX AS A PREDICTOR OF SEVERITY OF FIBROSIS IN CHRONIC HEPATITS C
KANNAN NARAYANAN, SUE ANN ZACHARIAH, SHEELA KURIAN V
Asian Journal of Pharmaceutical and Clinical Research.2023; : 69. CrossRef Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries
Caroline E Boeke, Lindsey Hiebert, Imam Waked, Tengiz Tsertsvadze, Lali Sharvadze, Maia Butsashvili, Mamuka Zakalashvili, Win Naing, Neil Gupta, Fredrick Kateera, Craig McClure, John W Ward, Christian B Ramers
Clinical Infectious Diseases.2022; 74(3): 513. CrossRef Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad
World Journal of Hepatology.2022; 14(6): 1053. CrossRef Drug-drug interactions with direct-acting antivirals — less is more
Grace Lai-Hung Wong
Clinical and Molecular Hepatology.2021; 27(1): 81. CrossRef Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals
Naglaa S Elabd, Safaa I Tayel, Moamena S Elhamouly, Shaimaa A Hassanein, Samar M Kamaleldeen, Fatma E Ahmed, Mahmoud Rizk, Abdelnaser A Gadallah, Soma E Ajlan, Ahmed S Sief
Hepatic Medicine: Evidence and Research.2021; Volume 13: 9. CrossRef Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, Alessio Aghemo
Viruses.2021; 13(6): 1048. CrossRef Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
Pil Soo Sung, Eui-Cheol Shin
International Journal of Molecular Sciences.2020; 21(7): 2583. CrossRef Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
Clinical and Molecular Hepatology.2020; 26(3): 251. CrossRef Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(11): 3414. CrossRef
|